Hospital acquired pneumonia (HAP) is the most frequent hospital acquired infection in England, but little is known about the national burden of the condition. Developing HAP has a pronounced detrimental effect on patient outcomes, increasing length of stay and mortality, and is associated with antimicrobial resistance.
This collaborative project between Liverpool University and the Advancing Quality Alliance (Aqua) investigates the scale of the national HAP burden based on findings from a North West regional initiative, the Advancing Quality (AQ) programme. Eight acute trusts have participated in the AQ HAP programme since October 2020, submitting monthly data on levels of care afforded to HAP patients. The project builds on this successful programme to expand the knowledge base and drive the recognition of HAP as a priority for research and policy.
Key publications and resources
For more information on this topic, we have a wide range of resources and publications on our HAP literature page.
Aqua Announces Directory of Offers 2023/24
Leading Integrated Teams: Aqua’s Impact on System Leadership Development
A New Partnership with Aqua and FMLM Applied
Aqua appoints three Special Advisors
System OD: Round Table and Tweet Chat
Acute Medics as Improvers: Fundamental Quality Improvement Skills for Clinicians